Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Offer Document Posted

2 Oct 2006 07:02

GE Fanuc Embedded Systems, Inc.02 October 2006 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY ORINDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE AVIOLATION OF THE RELEVANT LAWS IN THAT JURISDICTION FOR IMMEDIATE RELEASE 2 October 2006 RECOMMENDED CASH OFFER OF 410 PENCE PER SHARE FOR RADSTONE TECHNOLOGY PLC BY GE FANUC EMBEDDED SYSTEMS, INC. OFFER DOCUMENT POSTED Further to the announcement made on 18 September 2006 of a recommended cashoffer by GE Fanuc to acquire the entire issued and to be issued share capital ofRadstone, GE Fanuc announces that the offer document containing the full termsand conditions of the Offer dated 2 October 2006 (the "Offer Document") has beenposted to Radstone Shareholders today. If you hold Radstone Shares in certificated form, to accept the Offer, youshould complete, sign and return the Form of Acceptance, which accompanies yourOffer Document, in accordance with the instructions thereon and set out in theOffer Document as soon as possible and, in any event, so as to be received byCapita Registrars by no later than 3.00 p.m. (London time) on 23 October 2006. If you hold Radstone Shares in uncertificated form (that is, in CREST), toaccept the Offer you should accept the Offer electronically through CREST inaccordance with the instructions set out in the Offer Document so that the TTEInstruction settles by no later than 3.00 p.m. (London time) on 23 October 2006.If you hold Radstone Shares as a CREST sponsored member, you should refer toyour CREST sponsor as only your CREST sponsor will be able to send the necessaryTTE Instruction to CRESTCo. Copies of the Offer Document are available for inspection at the offices ofSlaughter and May, One Bunhill Row, London, EC1Y 8YY and will also be posted onGE Fanuc's website. Terms used in this announcement shall have the meaning given to them in theOffer Document. Enquiries: GE FanucMaryrose Sylvester (President and CEO) Tel: +1 434 978 5000Charles Alexander (President, GE Capital Europe) Tel: +44 (0)20 7302 6000 UBS Investment Bank (Financial adviser to GE Fanuc)Aidan Clegg Tel: +44 (0)20 7568 0000 Smithfield Financial (PR adviser to GE Fanuc)John Antcliffe Tel: +44 (0)20 7903 0665 RadstoneRhys Williams (Chairman) Tel: +44 (0)1327 359444Jeff Perrin (Chief Executive) Tel: +44 (0)1327 359444 Close Brothers (Financial adviser to Radstone)Andrew Cunningham Tel: +44 (0)20 7655 3100 JPMorgan Cazenove Limited (Corporate broker to Radstone)Julian Cazalet Tel: +44 (0)20 7588 2828 Buchanan Communications (PR adviser to Radstone)Tim Thompson Tel: +44 (0)20 7466 5000 UBS Investment Bank, which is authorised and regulated in the United Kingdom bythe Financial Services Authority, is acting exclusively for GE Fanuc and no oneelse in connection with the Offer and will not be responsible to anyone otherthan GE Fanuc for providing the protections afforded to its customers or forproviding advice in relation to the Offer, the contents of this announcement orany transaction or arrangement referred to herein. Close Brothers, which is authorised and regulated in the United Kingdom by theFinancial Services Authority, is acting exclusively as financial adviser forRadstone and no one else in connection with the Offer and will not beresponsible to anyone other than Radstone for providing the protections affordedto its customers or for providing advice in relation to the Offer, the contentsof this announcement or any transaction or arrangement referred to herein. JPMorgan Cazenove Limited, which is authorised and regulated in the UnitedKingdom by the Financial Services Authority, is acting exclusively as corporatebroker to Radstone and no one else in connection with the Offer and will not beresponsible to anyone other than Radstone for providing the protections affordedto its customers or for providing advice in relation to the Offer, the contentsof this announcement or any transaction or arrangement referred to herein. This announcement is not intended to and does not constitute, or form any partof, any offer to sell or any solicitation of any offer to purchase or subscribefor any securities or the solicitation of any vote or approval in anyjurisdiction. Any acceptance or other response to the Offer should be made onlyon the basis of the information contained or referred to in the Offer Documentand (in the case of holders of certificated Radstone shares only) the Form ofAcceptance. The availability of the Offer to persons who are not resident inthe United Kingdom may be affected by the laws of the relevant jurisdiction inwhich they are resident. Persons who are not resident in the United Kingdom, orwho are subject to the laws of any jurisdiction other than the United Kingdom,should inform themselves about the laws of such jurisdiction and observe anyapplicable requirements. The Offer will be made in the United States pursuantto an exemption from the US tender offer rules provided by the US Exchange Actand in Canada pursuant to certain exemptions from the takeover bid requirementscontained in applicable securities regulations. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company
17th Mar 20251:48 pmRNSDirector/PDMR Shareholding
14th Mar 20258:37 amRNSDirector/PDMR Shareholding
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.